Real-world emetic risk of chemotherapy and the corresponding antiemetic therapy in Japan: A study based on a nationwide database.
Ayako OkuyamaNarikazu BokuTakahiro HigashiPublished in: Cancer reports (Hoboken, N.J.) (2021)
The risk of CINV differs with cancer type. HEC was less prescribed compared with MEC. Most patients received the recommended anti-emetic prophylaxis.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- chemotherapy induced
- peritoneal dialysis
- papillary thyroid
- prognostic factors
- emergency department
- squamous cell carcinoma
- cross sectional
- radiation therapy
- stem cells
- young adults
- adverse drug
- patient reported
- cell therapy
- electronic health record